Both members of the NGF metabolic pathway identified symptomatic AD from the wider DS population with a sensitivity and specificity matching or outperforming that of the classical AD CSF biomarkers pTau, tTau, and the AB42/40 ratio (Pentz et al., 2021a). Here, NGF is linked to Alzheimer disease.